Olmesartan Medoxomil Jubilant Pharmaceuticals (Olmesartan Medoxomil)

Olmesartan medoxil is an ARB that lowers blood pressure by blocking the effects of angiotensin II.

• Hypertension: Helps reduce systolic and diastolic blood pressure in adults.
• Heart failure: Contributes to improved cardiac output and symptom control when used with other heart‑failure therapies.
• Diabetic nephropathy: Slows progression of kidney damage associated with type 2 diabetes.
• Post‑myocardial infarction: Assists in blood‑pressure control to lower the risk of further cardiovascular events.
• Stroke prevention: Aids in long‑term blood‑pressure management to reduce recurrent stroke risk.

• Olmesartan medoxil selectively blocks the binding of angiotensin II to the AT‑1 receptors on vascular smooth‑muscle and adrenal cells. This inhibition prevents vasoconstriction and aldosterone secretion, leading to vasodilation, reduced peripheral resistance, and lower blood pressure. The drug’s action is dose‑dependent and reversible, providing sustained antihypertensive effects throughout the dosing interval.

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Dizziness or light‑headed when standing.
• Headache.
• Fatigue.
• Nasal congestion.
• Diarrhoea.
• Mild elevation of blood‑urea nitrogen.

Serious or Rare Side Effects

• Angio‑edema involving the face, lips or tongue.
• Severe hypotension, especially after dose initiation.
• Acute kidney injury or worsening renal function.
• Hyperkalemia.
• Liver enzyme abnormalities.
• Allergic skin reactions such as rash or urticaria.

Olmesartan medoxil should be used with caution in specific clinical situations and according to professional guidance.

• Pregnancy: Contra‑indicated in the second and third trimesters due to fetal toxicity risk.
• Breastfeeding: Not recommended as it may pass into breast milk.
• Renal impairment: Dose adjustment may be required; monitor kidney function.
• Electrolyte balance: Monitor serum potassium, especially with potassium‑sparing diuretics.
• Drug‑induced hypotension: Advise patients to rise slowly from sitting or lying positions.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Olmesartan medoxil has several potential drug‑interactions that may require monitoring or avoidance.

Major Interactions (Avoid)

• Concomitant use with  N‑  N‑         

-   -  Moderate